Drug Research
Vectura and Inspira Pharmaceuticals Sign Agreement to Develop Potential Inhaled Treatment for COVID-19
Vectura Group plc, an industry leading inhalation CDMO, and Inspira Pharmaceuticals Limited, a new UK-based company focused on developing therapies for respiratory and infectious diseases, announced an agreement to develop an inhaled formulation of Inspira’s lead drug candidate for...
Clinical Trials
Cryoport and LabConnectPartner to Provide Support for Innovative Triumvira Cell and Gene Therapy Clinical Trial
LabConnect, Inc. and Cryoport, Inc. announced a partnership to provide comprehensive logistics support for an upcoming Phase I/II clinical trial sponsored by Triumvira Immunologics Inc., a privately held biopharmaceutical company developing a novel platform for engineering T cells to...
Press Releases
Moderna Announces Emergency Use Listing Granted by the World Health Organization for its COVID-19 Vaccine
Moderna, Inc. , a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the World Health Organization (WHO) has issued Emergency Use Listing (EUL) for its COVID-19 vaccine to prevent COVID-19 in individuals 18 years of age...
Drug Research
Moderna Announces Additional Investments to Increase Global Supply for COVID-19 Vaccine to up to 3 Billion Doses in 2022
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced it is making new funding commitments to increase supply at its owned and partnered manufacturing facilities, which it expects will increase global 2022 capacity to up...
Press Releases
Lonza and Moderna Enter New Agreement to Double Drug Substance Production for COVID-19 Vaccine in Visp
Lonza announced the expansion of its collaboration with Moderna, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, to manufacture the drug substance for the COVID-19 Vaccine Moderna.
The expanded collaboration provides for the installation of three additional drug...
Press Releases
Catalent and Stirling Ultracold Announce Partnership to Establish Energy-Efficient Cold Chain Capabilities for Biologics and Emerging Modalities
Catalent, the leading global provider of advanced delivery technologies, development, manufacturing, and clinical supply solutions for drugs, biologics, cell and gene therapies, and consumer health products, and Stirling Ultracold, the innovative developer and manufacturer of ultra-low temperature (ULT) freezers...
Packaging & Labelling
FedEx delivers critical healthcare supplies to India to support the fight against COVID-19
FedEx Express, a subsidiary of FedEx Corp. and one of the world’s largest express transportation companies, is working with organizations around the world to deliver critical medical supplies and equipment to assist in the fight against COVID-19 in India.
An...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















